Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Ulimorelin Study of Efficacy and Safety (ULISES 008)

ClinicalTrials.gov ID: NCT01296620

Public ClinicalTrials.gov record NCT01296620. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Ulimorelin Administered Post-Operatively to Accelerate Recovery of Gastrointestinal (GI) Motility in Subjects Who Have Undergone Partial Bowel Resection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Post-operative administration of ulimorelin is expected to reduce time to recovery of Gastrointestinal (GI) function in patients who have undergone partial large bowel resection

Study identification

NCT ID
NCT01296620
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Tranzyme, Inc.
Industry
Enrollment
330 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2011 (Type not available)
Primary completion
Mar 2012 (Actual)
Completion
Mar 2012 (Actual)
Last update posted
Jul 26, 2012

2011 – 2012

United States locations

U.S. sites
26
U.S. states
15
U.S. cities
23
Facility City State ZIP Site status
Glendale Memorial Hospital Glendale California 91204 —
Long Beach Memorial Medical Center Long Beach California 90806 —
Univ. of Southern California Los Angeles California 90033 —
Cedars Sinai Medical Center Los Angeles California 90048 —
Palo Alto VA Health Care Ctr Palo Alto California 94304 —
Citrus Memorial Hospital Inverness Florida 34452 —
Pensacola Research Consultants Pensacola Florida 32504 —
Tampa General Hospital Tampa Florida 33606 —
ARS Clinical Trials Powder Springs Georgia 30127 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
NOLA CVT Surgery New Orleans Louisiana 70115 —
Tufts Medical Center Boston Massachusetts 02111 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
CRC of Jackson Jackson Mississippi 39202 —
Mount Sinai Hospital New York New York 10021 —
Sanford Medical Center Fargo North Dakota 58122 —
Kaiser Permanente Northwest Clackamas Oregon 34452 —
Oregon Health and Science University Portland Oregon 97239 —
Forbes Regional Hospita Monroeville Pennsylvania 15146 —
Allegheny General Hospital Pittsburgh Pennsylvania 15212 —
VA Pittsburgh Health Care System Pittsburgh Pennsylvania 15241 —
Access Clinical Trials, Inc. Nashville Tennessee 37203 —
Texas Tech University Health Sciences Center El Paso Texas 79905 —
Southwest Surgical Associates Houston Texas 77074 —
VCU Medical Center Richmond Virginia 23219 —
MultiCare Research Institute Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01296620, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 26, 2012 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01296620 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →